Sheel Bio. Stock Price Today (NSE: SHEEL)

Sheel Bio.

80.00+0.00 (+0.00%)
Market Open

Fundamental Score

...

Sheel Bio. Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Sheel Bio. share price today is 80.00, up +0.00% on NSE/BSE as of 27 April 2026. Sheel Bio. (SHEEL) is a Small-cap company in the Diversified Commercial Services sector with a market capitalisation of 162.82 (Cr). The 52-week high for SHEEL share price is N/A and the 52-week low is N/A. At a P/E ratio of 11.34x, SHEEL is currently trading below its industry average P/E of 23.64x. The company has a Return on Equity (ROE) of 13.27% and a debt-to-equity ratio of 0.32.

Sheel Bio. Share Price Chart — NSE/BSE Historical Performance

No data
High
80.00
Low
80.00
Volume
0
Change
+0.00%

Sheel Bio. share price chart: 0.00% return over the past month. 52-week high ₹N/A, 52-week low ₹N/A.

AI Research Briefing

Powered by Gemini · 2026-04-27

Micro-cap agri-biotech play with concentrated promoter ownership and liquidity risk; avoid unless you have deep knowledge of the sector.

Research Confidence
5.0/10Moderate
MICRO-CAP DARK HORSEBreakdown - 3M: -32.77%Cheap - P/E of 8.36x vs industry P/E of 14.42x

WHAT'S HAPPENING NOW (last 2-4 weeks)

No major catalysts found after live search. Last update was on April 9, 2026, regarding corporate announcements.

CORE STORY (THE REAL GAME)

Agri-biotech play, focusing on tissue culture and organic farming, not just another agriculture company.

Why Now
  • Strong Qtr YoY Profit
  • Reasonable Valuation
  • High promoter holding
Potential Catalysts
  • Favorable monsoon and increased agri output
  • New contract wins
  • Successful FPO management
Key Risks
  • Micro-cap liquidity risk
  • Dependence on favorable monsoon
  • Potential for creative accounting
Institutional Activity

Promoter holding high at 71.26%, no change

Macro Context

General elections in progress, potential for policy changes impacting agriculture

Cash Flow Quality

No free cash flow data available

3–6 Month Outlook

Focus on tissue culture and organic farming could drive growth. Monitor monsoon and agri output closely.

Primary Thesis Risk

Unfavorable monsoon can decimate earnings.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

13.27%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

14.48%

Returns generated on total capital deployed

Good

Oper. Profit Margin (5Y Avg)

11.37%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Sheel Bio. Valuation Check

Excellent

Price to Earnings (P/E)

11.34x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

23.64x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

71.26%

% shares held by company founders/management

FII Holding

N/A

% shares held by foreign institutional investors

DII Holding

N/A

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

105.03%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

93.71%

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.32x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

8.07x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

N/A

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Sheel Bio. Fundamental Analysis & Valuation Benchmarking

Educational evaluation of SHEEL across key market metrics for learning purposes.

Positive Indicators

6 factors identified

Attractive Valuation (P/E: 11.34 vs Industry: 23.64)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Robust Profit Growth (105.03%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (93.71%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Strong Interest Coverage (8.07x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (71.26%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

1 factors identified

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Sheel Bio. vs Diversified Commercial Services Peers

Peer Comparison -

Compare Sheel Bio. with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
49/100
80
₹162.82
11.3
Average
13.27%
Average
14.48%
Average
0.3
Excellent
0.00%
47/100
370
₹14200.73
27.8
Average
54.37%
Excellent
68.01%
Excellent
0.1
Excellent
0.76%
Nesco Ltd...
NESCO505355
62.7/100
1220
₹8886.83
21.5
Average
15.82%
Good
21.12%
Excellent
0.0
Excellent
10.75%
Good
11.14%
Good
0.52%
30/100
547
₹7889.31
44.7
Average
137.07%
Excellent
22.7
Poor
20.61%
Excellent
22.95%
Excellent
0.00%
46.3/100
309
₹5807.52
16.2
Average
17.06%
Good
23.67%
Excellent
0.1
Excellent
21.89%
Excellent
11.88%
Good
1.84%
42.5/100
450
₹5346.96
-81.99%
Poor
6.97%
Poor
8.6
Poor
40.21%
Excellent
0.00%
19.1/100
124
₹4910.55
33.9
Average
3.46%
Poor
4.74%
Poor
0.4
Excellent
1.48%
43.4/100
164
₹4541.16
-234.10%
Poor
4.76%
Poor
8.7
Poor
34.61%
Excellent
0.00%
Nirlon Ltd...
NIRLON500307
59.1/100
616
₹4469.06
14.1
Average
59.88%
Excellent
30.18%
Excellent
2.5
Poor
14.71%
Good
15.46%
Excellent
5.24%
29.5/100
16
₹4441.00
251.2
Average
0.2
Excellent
9.53%
Good
0.00%
14.7/100
143
₹3889.84
-1.99%
Poor
-0.73%
Poor
0.2
Excellent
0.00%

Sheel Bio. Quarterly Performance

Latest quarterly metrics for SHEEL — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

93.71%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

105.03%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Sheel Bio. Financial Statements

Annual income statement, balance sheet and cash flow for Sheel Bio. (SHEEL) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Sheel Bio.

About SHEEL (Sheel Bio.)

Sheel Bio. (SHEEL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Diversified Commercial Services sector with ...a current market capitalisation of ₹162.82 (Cr). Sheel Bio. has delivered a Return on Equity (ROE) of 13.27% and a ROCE of 14.48%. The debt-to-equity ratio stands at 0.32, reflecting the company's capital structure. Investors tracking SHEEL share price can monitor key metrics including P/E ratio, promoter holding of 71.26%, and quarterly earnings growth.

Company Details

Symbol:SHEEL
Industry:Diversified Commercial Services
Sector:N/A
Website:N/A

SHEEL Share Price: Frequently Asked Questions

What is the current share price of Sheel Bio.?

Sheel Bio. (SHEEL) trades at ₹80.00 on NSE. Market cap ₹162.82 (Cr). Educational data only.

What is the P/E ratio of Sheel Bio.?

Sheel Bio. has a P/E of 11.34x vs industry average 23.64x.

What is the Bull Run score for Sheel Bio.?

Sheel Bio. has a Bull Run score of 49/100 based on 25+ financial parameters.

Does Sheel Bio. pay dividends?

Sheel Bio. has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Sheel Bio.?

Sheel Bio. has ROE of 13.27%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Sheel Bio.?

Sheel Bio. has debt-to-equity of 0.32.

Is Sheel Bio. a good investment?

Bull Run gives Sheel Bio. a score of 49/100. This is not investment advice — consult a SEBI-registered advisor.